Lipid metabolism and Alzheimer's disease: pathways and possibilities.
Alzheimer's disease (AD) is a growing condition in dire need of new therapeutics for its cure. Currently marketed drugs only provide symptomatic relief and do not intervene in disease-modifying pathways. Deposition of amyloid beta peptides in the brain is considered to be at the core of pathological events in AD. Studies indicate that lipid/lipoprotein metabolism has a role in several steps in the etiology of AD. Here we review the molecular pathways by which lipid metabolism may influence AD and could form the basis for design of new disease modifying therapeutics. Modulation of lipid metabolism has excellent potential to provide new avenues for disease modifying drugs for AD.